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In this issue of Chemistry & Biology, Ishida and colleagues [1] report on the characterization of new
aeruginoside metabolites and the respective NRPS gene cluster in the cyanobacterium Planktothrix
agardhii.Cyanobacteria are among the most
talented, culturable micro-organisms
from which novel, structurally diverse,
biochemically active natural products
have been isolated. Many of the com-
pounds are small nontoxic or toxic
peptides with unusual amino acids,
polyketides, or hybrids of different
biosynthetic pathways [2, 3].
Cyanobacteria are structurally di-
verse, geographically widespread in
freshwater, marine, and terrestrial hab-
itats, and some genera are nitrogen
fixing and are therefore of great impor-
tance for the natural balance of the
ecology.Due to the production of highly
active hepatotoxins and neurotoxins,
increasingly common cyanobacterial
water blooms are of serious concern
in freshwater reservoirs or lakes [2, 3,
4]. Investigating these toxins and other
bioproducts with a focus on cancer
drug discovery and chemical ecology
is a promising research field where
culturable cyanobacteria play an out-
standing role. Diverse metabolites
with relevant pharmaceutical activities
have been isolated from cyanobacteria.
However, the true relevance of these
highly active agents for the producer
strains remains elusive at present.In this issue of Chemistry & Biology
[1], two analogs of cyanobacterial
aeruginosides, produced by the genus
Oscillatoria (syn. Planktothrix), are re-
ported. More than 200 compounds
originate from different species of the
order Oscillatoriales [2]. In the last
decade, the toxic Planktothrix agardhii
received considerable attention, and
was recognized as a prolific source of
novel metabolites [5]. Several com-
pounds from different chemical clas-
ses are currently known. These include
the first aeruginosins (205A and 205B)
reported from P. agardhii that were
highlighted as glycopeptides inhibiting
serine proteases [6], several variants of
the hepatotoxin complex microcystin
isolated from a single strain [7], and
the multicyclic microviridins that are
the largest known cyanobacterial oli-
gopeptides with characteristic ester
and secondary amino bonds [3]. How-
ever, the full spectrum of chemical
compounds produced by different iso-
lates of the P. agardhii species has not
been cataloged. Perhaps more inter-
estingly, the whole metabolite pattern
of a single strain as a distinct cocktail
of bioactive agents has not been
investigated in detail with respect toChemistry & Biology 14, May 2007 ªits ecological and physiological rele-
vance; although, Fujii and coworkers
[5] gave some initial insights.
The approach taken by Ishida and
colleagues [1] is a sophisticated
application of the general knowledge
about the organization of nonriboso-
mal peptide synthetase (NRPS) bio-
synthetic gene clusters in cyanobacte-
ria to probe a yet unexplored part of
the metabolite pattern of P. agardhii
strain CYA 126/8. The method used el-
egantly turns around a classic concept
in natural product research. Typically,
a biosynthetic gene cluster is identified
long after the respective metabolite is
identified and fully characterized in
a chemical-pharmaceutical screening
program [8]. In the new report, a
NRPS gene sequence was identified
by a degenerate PCR approach in
Planktothrix and used for insertional
mutagenesis with a chloramphenicol
resistence cassette to give evidence
for the involvement of the genes within
the cluster in putative peptide biosyn-
thesis. Importantly, parallel cultivation
of wild-type cells and mutant cells
called attention to previously unknown
metabolites. Subsequent careful
chemical analysis identified two new2007 Elsevier Ltd All rights reserved 469
Chemistry & Biology
Previewsaeruginosides, 126A and 126B, glyco-
sylated peptides that consist of an
N-terminal aryl lactic acid, D-leucine,
the characteristic Choi moiety and a
C-terminal arginine analog (Aeap). Ad-
ditionally, one strong point of the ap-
proach [1] is the independence from
pharmaceutically relevant bioactivities
as the sole guidance for metabolite
screening since 126A and 126B lack
striking activity in standard tests. How-
ever, their functions need to be exam-
ined as they might be of importance
for physiological and ecological pro-
cesses in the producer strain, or for ac-
tivity screens other than those normally
used in pharmaceutical test systems.
An interesting question is whether
the concept used by Ishida and col-
leagues [1] can lead to the discovery
of additional peptide families encoded
in the genome of this individual cyano-
bacterial strain. It would be of great in-
terest to add yet unknown structures
to the metabolite pattern ofP. agardhii,
even if they are restricted to NRPS-
derived products with this strategy.
Finding a so-called ‘‘silent biosynthetic
gene cluster,’’ one not related to obvi-
ous metabolite production under lab
conditions, would be an advanced
challenge for both biologists and
chemists, and could mirror the organ-
ism’s full biosynthetic potential. Other
screening approaches might add to
the picture of P. agardhii as an extra-
ordinarily talented cyanobacterial
producer strain [5].
Beyond understanding how the
metabolites are made, there is direct,
compound driven interest (potential
pharmaceutical or cosmeceutical) in
microbial, here cyanobacterial, me-
tabolism. The diversity of chemical re-
actions performed with biochemical
(i.e., enzymatic) means has attracted
increasing interest from the chemical
industry. Considering the growing im-
portance of establishing ‘‘green’’ sus-
tainable production processes, more
and morechemicalprocesses are being
switched to biotechnological routes [9].
Moreover, ‘‘green’’ products will play an
important role per se in the rapidly ex-
panding field of dietary supplements to
improve ‘‘beautyandhealth’’bydisease
prevention, an emerging sector filling
the gap between nutrition and classical
pharmaceutical therapies [10].470 Chemistry & Biology 14, May 2007 ªThe goal of industrial or white
biotechnology is to provide the tech-
nologies (biological routes and sys-
tems) and discoveries to develop
suitable pathways and biocatalysts in
‘‘green’’ production processes. Stud-
ies on biosynthetic routes to com-
pounds featuring rare moieties (e.g.,
the Choi moiety described in this issue
[1]) or special reaction types and tai-
loring activities have the potential to
identify enzymes of interest. Enzymes
capable of Michael addition (like AerE
[1]), Friedel-Crafts-type electrophilic
substitutions [11], or halogenases and
prenyl transferases [12, 13, 14] provide
excellent insights into the workings
and capabilities of biological pro-
cesses and importantly provide tools
for biotechnological applications.
The concept of microbial diversity
has dramatically expanded in recent
years. However, according to Amman
and coworkers [15] only a minority of
micro-organisms living in any given
habitat are cultivable, possibly due to
complex interspecies associations in
biofilms or symbiosis. In fact, studies
by Torsvik and coworkers [16] and
especially Venter and coworkers [17]
defined the enormous dimensions of
biological (i.e., molecular) diversity
as a nearly inexhaustible resource of
genes and pathways for biotechnolog-
ical/industrial applications. Currently
only metagenomics has the potential
to make this entire resource available
since this technology comprises the
application of the genomics methods
to the complete genomes of all mi-
cro-organisms living in a defined
habitat. On the other hand, it is initially
important to explore in detail the bio-
synthetic and metabolic treasures of
particular phyla of microbial life. Stud-
ies such as the one in this issue [1] give
detailed functional insights into the
biosynthetic capabilities and hence
enzymes or bioactive compounds are
available for industrial driven investi-
gations.
Two goals, the urgent need for ther-
apeutic agents and the interest in un-
derstanding/using biological systems,
are inherently connected and currently
guide molecular cyanobacterial re-
search. For example, it remains elu-
sive whether a regulatory network of
the different metabolites exists. The2007 Elsevier Ltd All rights reservedauthors’ research on aeruginosides
builds an ideal basis for such investi-
gations either in the lab or in a natural
habitat [1, 18]. Great interest in this
area comes particularly from the rise
of pathogenic bacteria in clinical set-
tings. There, the aim is to successfully
defeat the microorganisms. In a related
example, we are keen to understand
the functional role of secondary me-
tabolites, for example microcystin, in
planktonic cyanobacterial communi-
ties where they might comprise graz-
ing protection or cell-cell signaling
mechanisms. Future research might
take the exciting direction of consi-
dering that the comprehensive group
of structural variants and relative
amounts of compounds produced by
a single bacterial species is important
as a very distinct cocktail of biological
interacting chemicals with ecological
advantages and consequences for
the producer.
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